R S Walters - Concepedia

Concepedia

Author

R S Walters

The University of Texas MD Anderson Cancer Center

Also Known As

R S Walters, R Walters, R. S. Walters, R. Walters, R.S. Walters, Raymond Walters, Jr.

29

Publications

2.8K

Citations

18

H-Index

27

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Breast Cancer Care Anderson Hospital

RS

About

R S Walters is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.6K
2	Health Sciences	5	5	583
3	Emergency Medicine	2	2	192
4	Engineering	1	1	14
5	Blood Transplantation	1	1	170

R S Walters

×

20

Publications

2.8K

Citations

18

H-Index

	Year	Citations
Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer Frankie A. Holmes, R S Walters, R. Theriault, JNCI Journal of the National Cancer Institute Metastatic Breast CancerOncologyActive DrugPhase Ii TrialHouston Tx 77030	1991	745
Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer. Vicente Valero, Frankie A. Holmes, R S Walters, Journal of Clinical Oncology	1995	387
Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. Hagop M. Kantarjian, Michael J. Keating, R S Walters, Journal of Clinical Oncology Hematological MalignancyHealth SciencesMedicineMixed-phenotype Acute LeukemiaMalignant Blood Disorder	1986	266
Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome. Michael J. Keating, Terry L. Smith, H. Kantarjian, PubMed	1988	218
Response to salvage therapy and survival after relapse in acute myelogenous leukemia. Michael J. Keating, Hagop M. Kantarjian, Terry L. Smith, Journal of Clinical Oncology Hematological MalignancyMedian SurvivalMedicineMixed-phenotype Acute LeukemiaMalignant Blood Disorder	1989	174
Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. Hagop M. Kantarjian, R S Walters, Michael J. Keating, Journal of Clinical Oncology Mixed-phenotype Acute LeukemiaImmunologyInduction MortalityPharmacotherapyImmunotherapy	1990	170
Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer. Frankie A. Holmes, Timothy Madden, Robert A. Newman, Journal of Clinical Oncology	1996	166
Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor Saroj Vadhan‐Raj, S Buescher, A LeMaistre, Blood	1988	132
Therapy of chronic myelogenous leukemia with recombinant interferon- gamma Razelle Kurzrock, Moshe Talpaz, H Kantarjian, Blood	1987	88
The characteristics and outcome of patients with late relapse acute myelogenous leukemia. Hagop M. Kantarjian, M Keating, R S Walters, Journal of Clinical Oncology Hematological MalignancyMyelogenous LeukemiaOncologyHealth SciencesEarlier Relapse	1988	84

Page 1